<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01018888</url>
  </required_header>
  <id_info>
    <org_study_id>1PN1010941</org_study_id>
    <nct_id>NCT01018888</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy Study of Artificial Cornea</brief_title>
  <acronym>AuroKPro</acronym>
  <official_title>Clinical Assessment of Auro KPro</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aurolab</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aurolab</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the stability of artificial cornea manufactured by
      Aurolab and to assess its visual outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The keratoprosthesis, also know as an artificial cornea plays a significant role in combating
      corneal blindness in patients who are no longer candidates for penetrating keratoplasty.The
      global incidence of corneal blindness is estimated to be 6-8 million. In India there are
      approximately 6.8 million cases of unilateral corneal blindness and 1.3 million people with
      bilateral corneal pathology.

      Eligible subjects after getting informed consent will be included in this study. All the
      subjects will have pre-operative evaluation which includes history, visual acuity,
      Intraocular pressure (IOP), evaluation of tear film and ultrasound A and B scan. Ocular
      inflammation will be controlled prior to surgery. Keratoplasty will be performed with
      keratoprosthesis under local anesthesia. Patients will be followed up at regular interval to
      assess the outcome variables.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2010</start_date>
  <completion_date type="Anticipated">July 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Visual Acuity</measure>
    <time_frame>1st Month, 2nd Month, 3rd Month,5th Month, 7th Month, 9th Month and 12th Month</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Retention of the device</measure>
    <time_frame>1st Month, 2nd Month, 3rd Month,5th Month, 7th Month, 9th Month and 12th Month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Corneal Transplantation</condition>
  <arm_group>
    <arm_group_label>Keratoprosthesis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Auro KPro (Keratoprosthesis)</intervention_name>
    <description>Front plate with optical cylinder, a back plate and a titanium ring to hold the complex together</description>
    <arm_group_label>Keratoprosthesis</arm_group_label>
    <other_name>Auro KPro</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age more than 20 years

          -  Willing to participate and review on schedule

          -  Multiple failed grafts with poor prognosis for regrafting

          -  Adequate tear film and lid function

          -  Projection of light in all quadrants

          -  Bilateral blind

        Exclusion Criteria:

          -  Reasonable chance of success with keratoplasty

          -  Autoimmune disease such as Stevens Johnson Syndrome, Pemphigoid

          -  End stage glaucoma

          -  Retinal detachment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr. Jeena Mascarenhas, MBBS, MS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Aravind Eye Hospital, Madurai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mr.Karthikumar S, M.Pharm</last_name>
    <phone>0452-3096100</phone>
    <phone_ext>229</phone_ext>
    <email>crd@aurolab.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Elakiya S, M.Sc</last_name>
    <phone>0452-4356100</phone>
    <phone_ext>364</phone_ext>
    <email>sicca@aravind.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Aravind Eye Hospital</name>
      <address>
        <city>Madurai</city>
        <state>Tamil Nadu</state>
        <zip>625 020</zip>
        <country>India</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mr. Gobinath , B.Pharm</last_name>
      <phone>0452-4356100</phone>
      <phone_ext>364</phone_ext>
      <email>clinicalresearch@aravind.org</email>
    </contact>
    <contact_backup>
      <last_name>Muthu Selvi, BA., BBE</last_name>
      <phone>0452-4356100</phone>
      <phone_ext>364</phone_ext>
      <email>clinicaltrials@aravind.org</email>
    </contact_backup>
    <investigator>
      <last_name>Dr. Jeena Mascarenhas Mascarenhas, MBBS, MS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>India</country>
  </location_countries>
  <verification_date>July 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 24, 2009</study_first_submitted>
  <study_first_submitted_qc>November 24, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 25, 2009</study_first_posted>
  <last_update_submitted>January 7, 2013</last_update_submitted>
  <last_update_submitted_qc>January 7, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 8, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cornea</keyword>
  <keyword>Transplantation, Cornea</keyword>
  <keyword>Keratoplasty</keyword>
  <keyword>Grafting, Corneal</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

